Abstract:Background: Depressive symptoms are common in patients with cancer and more prevalent in Chinese patients. The Center for Epidemiologic Studies Depression Scale is one of the most widely used self-report scales to assess depressive symptoms in both community and hospitalized samples. A revised Center for Epidemiologic Studies Depression Scale has been created, but the evidence on psychometric properties is limited. Objectives: To develop the Chinese version of the scale, and to examine the cross-cultural validity, structural validity, construct validity, internal consistency, test-retest reliability, measurement error, responsiveness, and floor/ceiling effect of the scale among patients with cancer according to the recommendation in the consensus-based standards for the selection of health status measurement instruments checklist. Design: A cross-sectional survey design with 33 participants (approximately 10%) completing the followup survey for evaluating the test-retest reliability. Settings: Randomly selected eight wards of an oncology hospital in China. Participants: Of the 595 patients we approached in the randomly selected eight wards, 310 gave their informed consent and completed the survey. Methods: The Chinese version of the Center for Epidemiologic Studies Depression Scale-Revised was developed by four researchers (two translators and two reviewers) who were proficient in both English and Chinese. Participants completed the scale and the depression module of the Patient Health Questionnaire. Principal components analyses, Spearman's correlation, the Mann-Whitney U test, Cronbach's alpha, and the intraclass correlation coefficient were used. Results: The cross-culture validity was excellent based on the consensus-based standards for the selection of the health status measurement instruments checklist. A two-factor structure was determined: somatic symptoms and affective-cognitive symptoms. The sufficient construct validity was supported by that the score of the Center for Epidemiologic Studies Depression Scale-Revised was strongly correlated with the depression module of the Patient Health Questionnaire score (rho = 0.73, p < 0.001) and patients who had received chemotherapy (p = 0.002 )/radiotherapy (p = 0.035) reported higher scores of depression than those who have not. The Cronbach's alphas of the total scale and subscales ranged from 0.82-0.88. The test-retest reliability was sufficient (intraclass correlation coefficient = 0.73-0.81, all p < 0.001) for total scale and subscales. The smallest detectable change was 2.98 and the responsiveness was adequate, with no floor/ceiling effect. Conclusions: This study supports the Chinese version of the Center for Epidemiologic Studies Depression Scale-Revised as a valid and reliable measurement of depressive symptoms in patients with cancer. (C) 2019 Elsevier Ltd. All rights reserved.

Validation and application of the Chinese version of the Columbia-Suicide Severity Rating Scale: Suicidality and cognitive deficits in patients with major depressive disorder

Suicide Risk in Major Affective Disorder: Results from a National Survey in China.

Risk Factors for Recent Suicide Attempts in Major Depressive Disorder Patients in China: Results from a National Study

The Chinese Version of Oxford Depression Questionnaire: A Validation Study in Patients with Mood Disorders

Reliability and Validity of the Columbia Suicide Screen for Suicide Risk Assessment in Senior Middle School Students

Gender Differences in Prevalence and Associations Between Cognitive Symptoms and Suicidal Ideation in Patients with Recurrent Major Depressive Disorder: Findings from the Chinese NSSD Study

Validation of the Chinese Version of the Cornell Scale for Depression in Dementia and Its Applications for Clinical Research

Validating A Short Version Of The Suicide Intent Scale In China

Validation of the Chinese version of the Coma Recovery Scale-Revised (CRS-R).

Reliability and validity of the Center for Epidemiological Studies Depression Scale in 2 special adult samples from rural China

Gut Microbial Trajectory in Patients with Bipolar Depression: A Longitudinal Study

Reliability and Validity of the Center for Epidemiologic Studies Depression Scale (CES-D) among Suicide Attempters and Comparison Residents in Rural China.

Psychometric validation of the Columbia-Suicide Severity rating scale in Spanish-speaking adolescents

Reliability and Validity of the Chinese Version of the Calgary Depression Scale for Schizophrenia

Perceived Stressfulness Mediates the Effects of Subjective Social Support and Negative Coping Style on Suicide Risk in Chinese Patients with Major Depressive Disorder.

Psychometric Properties of the Chinese Version of the Center for Epidemiologic Studies Depression Scale-Revised in Patients with Cancer: A Cross-Sectional Study.

Prevalence of Suicidality in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Comparative Studies

Validity and reliability of a Chinese language suicide screening questionnaire-observer rating (CL-SSQ-OR) assessment for children/adolescents

Validity of Chinese Version of the Composite International Diagnostic Interview-3.0 in Psychiatric Settings.

Connectomics-based Resting-State Functional Network Alterations Predict Suicidality in Major Depressive Disorder.

Exploring the neurocognitive correlates of suicidal ideation in major depressive disorder: The role of frontoparietal and default mode networks